Leidos Holdings Other Non-Current Liabilities decreased by 0.4% to $267.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.8%, from $317.00M to $267.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -1.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $275.00M | $285.00M | $283.00M | $267.00M | $195.00M | $198.00M | $229.00M | $233.00M | $256.00M | $279.00M | $314.00M | $267.00M | $289.00M | $299.00M | $341.00M | $315.00M | $317.00M | $311.00M | $270.00M | $268.00M | $267.00M |
| QoQ Change | — | +3.6% | -0.7% | -5.7% | -27.0% | +1.5% | +15.7% | +1.7% | +9.9% | +9.0% | +12.5% | -15.0% | +8.2% | +3.5% | +14.0% | -7.6% | +0.6% | -1.9% | -13.2% | -0.7% | -0.4% |
| YoY Change | — | — | — | — | -29.1% | -30.5% | -19.1% | -12.7% | +31.3% | +40.9% | +37.1% | +14.6% | +12.9% | +7.2% | +8.6% | +18.0% | +9.7% | +4.0% | -20.8% | -14.9% | -15.8% |